This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Shih Y-CT, Mauskopf J, Borker R.A cost-effectiveness analysis of first-line controller therapies for persistent asthma. PharmacoEconomics 25: 577-590, No. 7, 2007
Rights and permissions
About this article
Cite this article
Salmeterol/fluticasone of value for mild-to-moderate asthma. Pharmacoecon. Outcomes News 532, 1 (2007). https://doi.org/10.2165/00151234-200705320-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705320-00001